Drug comparisons
Canagliflozin vs Miglitol
Compare Canagliflozin and Miglitol for T2D. SGLT2 vs alpha-glucosidase inhibitors differ in mechanism, CV benefits, GI effects, and patient suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when adding a second oral agent after metformin in type 2 diabetes, weighing SGLT2 cardiorenal benefits against alpha-glucosidase postprandial control.
Bottom line
Neither drug is universally superior; Canagliflozin provides extra cardiovascular and renal protection while Miglitol offers targeted mealtime glucose lowering with a distinct side-effect profile.
All medication comparisons